Test Price
2,800 AEDโ Home Collection Available
HCN4 Gene Brugada Syndrome Type 8 Genetic Test (NGS) in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Genetic Counselling by DHA-licensed consultant medical geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HCN4 gene test for Brugada syndrome type 8 uses next-generation sequencing to identify pathogenic variants in the HCN4 gene, enabling definitive diagnosis, risk stratification, and cascade screening for this inherited primary arrhythmia syndrome.
| Feature | Our NGS Test | Conventional Sanger Sequencing |
|---|---|---|
| Precision | Full HCN4 gene coverage, >99% analytical sensitivity | Exon-by-exon sequencing, risk of missing deep intronic variants |
| Methodology | Next-Generation Sequencing (NGS) | Sanger Sequencing |
| Turnaround Time | 3 โ 4 Weeks | 5 โ 8 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
โA genetic diagnosis of Brugada syndrome type 8 requires careful interpretation of the HCN4 variant within the context of the patientโs ECG phenotype, family history, and clinical presentation. This test provides high sensitivity, but a negative result does not exclude the condition. I always recommend comprehensive pre- and post-test genetic counselling to ensure informed decision-making and appropriate cascade screening.โ
Medication Safety Advisory
Medication Safety Warning
Do not discontinue or adjust any prescribed heart or anti-arrhythmic medication without first consulting your DHA-licensed physician.
Safety Exclusion Criteria & Emergency Red Flags
- Sample collection safety: Inform the phlebotomist if you have a bleeding disorder or are on anticoagulant therapy.
- Emergency Red Flags: If you experience sudden fainting, severe palpitations, chest pain, or a racing irregular heartbeat, seek emergency medical care immediately. This genetic test is a diagnostic tool, not a replacement for acute cardiac evaluation.
- Pediatric testing: Testing for minors (<18 years) strictly requires parental/guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability, with a preโtest clinical genetic counselling session.
Patient FAQ & Clinical Guidance
1. What does a positive HCN4 genetic test mean?
A positive HCN4 test result indicates you carry a pathogenic mutation linked to Brugada syndrome type 8, directly increasing your risk of life-threatening ventricular arrhythmias. A comprehensive genetic counselling session is recommended to discuss implications and family screening.
2. How should I prepare for the blood sample collection?
No special fasting is required; simply provide your clinical history and inform the team of any blood-thinning medications you are taking. Our mobile phlebotomist will coordinate a convenient home visit.
3. Will my genetic data be kept confidential?
Yes, your genetic data is protected under the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All data is encrypted and accessible only to authorised clinicians.
UAE Regulatory & Data Privacy Adherence
This test is processed in an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139). All genetic counselling and data handling adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | HCN4 Gene Brugada Syndrome Type 8 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | I49.8 |
| LOINC Code | 94531-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians